Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
32,987
Sort by:
Xenazine - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Xenazine API intelligence over Xenazine and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Xeristar - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Xeristar API intelligence over Xeristar and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Xeroquel LP - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Xeroquel LP API intelligence over Xeroquel LP and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Xopenex - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Xopenex API intelligence over Xopenex and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Xtandi - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Xtandi API intelligence over Xtandi and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Xyrem - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Xyrem API intelligence over Xyrem and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Xyzall - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Xyzall API intelligence over Xyzall and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zactos - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zactos API intelligence over Zactos and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zaldiar - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zaldiar API intelligence over Zaldiar and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zeclar - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zeclar API intelligence over Zeclar and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zeffix - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zeffix API intelligence over Zeffix and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zelboraf - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zelboraf API intelligence over Zelboraf and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zelitrex - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zelitrex API intelligence over Zelitrex and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zemplar - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zemplar API intelligence over Zemplar and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zenhale - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zenhale API intelligence over Zenhale and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zienam - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zienam API intelligence over Zienam and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zient - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zient API intelligence over Zient and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zintrepid - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zintrepid API intelligence over Zintrepid and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zispin - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zispin API intelligence over Zispin and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zocor - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zocor API intelligence over Zocor and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zoloft - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zoloft API intelligence over Zoloft and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zoltec - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zoltec API intelligence over Zoltec and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zometa Concentrate - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zometa Concentrate API intelligence over Zometa Concentrate and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zortress - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zortress API intelligence over Zortress and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zosyn - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zosyn API intelligence over Zosyn and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zurcal - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zurcal API intelligence over Zurcal and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zyprexa - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zyprexa API intelligence over Zyprexa and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zytiga - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zytiga API intelligence over Zytiga and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Aciphex - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Aciphex API intelligence over Aciphex and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Acromegaly - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Acromegaly Key assessments Patient Segmentation in Acromegaly Acromegaly Risk & Burden Factors driving growth in a specific Acromegaly patient population
January 2022
60 pages
Acthar Gel - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Acthar Gel API intelligence over Acthar Gel and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Actinic Keratosis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Actinic Keratosis Key assessments Patient Segmentation in Actinic Keratosis Actinic Keratosis Risk & Burden Factors driving growth in a specific Actinic Keratosis patient population
January 2022
60 pages
Acute Coronary Syndrome - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Acute Coronary Syndrome Key assessments Patient Segmentation in Acute Coronary Syndrome Acute Coronary Syndrome Risk & Burden Factors driving growth in a specific Acute Coronary Syndrome patient population
January 2022
60 pages
Acute Coronary Syndrome - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Acute Coronary Syndrome Report Assessment Current Treatment Practices in Acute Coronary Syndrome Unmet Needs in Acute Coronary Syndrome Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...
January 2022
200 pages
Acute Renal Failure (ARF) (Acute Kidney Injury) - Epidemiology Forecast to 2032
US$ 3,950.00
... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Acute Renal Failure (ARF) (Acute Kidney Injury) Key assessments Patient Segmentation in Acute Renal Failure (ARF) (Acute Kidney Injury) Acute Renal Failure (ARF) (Acute Kidney Injury) Risk & Burden Factors driving growth ...
January 2022
60 pages
Acute Respiratory Distress Syndrome - Epidemiology Forecast to 2032
US$ 3,950.00
... strengths 10 Year Forecast 7MM Coverage Total Cases in Acute Respiratory Distress Syndrome Key assessments Patient Segmentation in Acute Respiratory Distress Syndrome Acute Respiratory Distress Syndrome Risk & Burden Factors driving growth in a specific Acute Respiratory Distress Syndrome patient population
January 2022
60 pages
Adempas - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Adempas API intelligence over Adempas and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Advair Diskus - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Advair Diskus API intelligence over Advair Diskus and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Akynzeo - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Akynzeo API intelligence over Akynzeo and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Allergic Rhino-Conjunctivitis - Epidemiology Forecast to 2032
US$ 3,950.00
... patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Allergic Rhino-Conjunctivitis Key assessments Patient Segmentation in Allergic Rhino-Conjunctivitis Allergic Rhino-Conjunctivitis Risk & Burden Factors driving growth in a specific Allergic Rhino-Conjunctivitis patient population ...
January 2022
60 pages
Alpha- Antitrypsin Deficiency - Epidemiology Forecast to 2032
US$ 3,950.00
... UK) Patient Population in various epidemiological segments Population at risk of AATD Prevalent Population of AATD Diagnosed Prevalence of AATD Gender Specific case of AATD Comorbidities associated with AATD Therapeutic Approaches Alpha- Antitrypsin Deficiency (AATD) Report Key Strengths 10 Year Forecast 6MM ...
January 2022
60 pages
Anaplastic Astrocytoma - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Anaplastic Astrocytoma Key assessments Patient Segmentation in Anaplastic Astrocytoma Anaplastic Astrocytoma Risk & Burden Factors driving growth in a specific Anaplastic Astrocytoma patient population
January 2022
60 pages
Anesthetic Effect - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Effect Pipeline Analysis Anesthetic Effect Market Size and Trends Anesthetic Effect Market Opportunities Impact of upcoming Therapies in Anesthetic Effect Anesthetic Effect Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2022
200 pages
Aneurysmal Subarachnoid Hemorrhage (SAH) - Epidemiology Forecast to 2032
US$ 3,950.00
... Forecast 7MM Coverage Total Cases in Aneurysmal Subarachnoid Hemorrhage (SAH) Key assessments Patient Segmentation in Aneurysmal Subarachnoid Hemorrhage (SAH) Aneurysmal Subarachnoid Hemorrhage (SAH) Risk & Burden Factors driving growth in a specific Aneurysmal Subarachnoid Hemorrhage (SAH) patient population ...
January 2022
60 pages
Angina (Angina Pectoris) - Epidemiology Forecast to 2032
US$ 3,950.00
... with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Angina (Angina Pectoris) Key assessments Patient Segmentation in Angina (Angina Pectoris) Angina (Angina Pectoris) Risk & Burden Factors driving growth in a specific Angina (Angina Pectoris) patient population
January 2022
60 pages
Angiox - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Angiox API intelligence over Angiox and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Ankylosing Spondylitis (Bekhterev's Disease) - Epidemiology Forecast to 2032
US$ 3,950.00
... with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Ankylosing Spondylitis (Bekhterev's Disease) Key assessments Patient Segmentation in Ankylosing Spondylitis (Bekhterev's Disease) Ankylosing Spondylitis (Bekhterev's Disease) Risk & Burden Factors driving growth ...
January 2022
60 pages
Anoro Ellipta - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Anoro Ellipta API intelligence over Anoro Ellipta and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
